1,012
Views
4
CrossRef citations to date
0
Altmetric
Research Paper

Safety, immunogenicity of lyophilized purified vero cell cultured rabies vaccine administered in Zagreb and Essen regimen in post-exposure subjects: A post-marketing, parallel control clinical trial

, ORCID Icon, , , , , , , & show all
Pages 2547-2553 | Received 07 Oct 2020, Accepted 18 Dec 2020, Published online: 25 Feb 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Xiaoyuan Huang, Jing Liang, Lili Huang, Xuanxuan Nian, Wei Chen, Jiayou Zhang, Xiao Xu, Xuan Lin, Yue Wang, Jinrong Shi, Lanxin Jia, Qingliang Li, Qianxi Wang, Kai Duan, Xinguo Li, Yaqi Ji, Feixia Peng, Wei Zhang, Zhiqiang Xie, Yanxia Wang & Xiaoming Yang. (2023) Safety and immunogenicity of rabies vaccine (PVRV-WIBP) in healthy Chinese aged 10–50 years old: Randomized, blinded, parallel controlled phase III clinical study. Human Vaccines & Immunotherapeutics 19:1.
Read now
Wei Zhang, Yingfei Guo, Fei She, Shuangqing Liu, Xin Du & Hongsheng Liu. (2022) Analysis of Factors Influencing the Course of Rabies Vaccinations: One Year Study on Compliance of Rabies Vaccination Regimens in Haidian District of Beijing. Patient Preference and Adherence 16, pages 2913-2920.
Read now

Articles from other publishers (2)

Pavle Banović, Dragana Mijatović, Verica Simin, Nenad Vranješ, Eleftherios Meletis, Polychronis Kostoulas, Dasiel Obregon & Alejandro Cabezas-Cruz. (2024) Real-world evidence of rabies post-exposure prophylaxis in Serbia: Nation-wide observational study (2017–2019). Travel Medicine and Infectious Disease 58, pages 102697.
Crossref
Xiaohong Wu, Jia Li, Lei Zhou, Jianmin Chen, Zhongqiang Jin, Qingwei Meng, Jing Chai, Hongxia Gao, Yunpeng Wang, Danhua Zhao, Heng Wu, Jieran Yu, Nan Chen, Yanan Wang, Yuan Lin, Peifang Huang, Yuhua Li & Yuhui Zhang. (2023) A Randomized, Double-Blind, Controlled Phase III Clinical Trial to Evaluate the Immunogenicity and Safety of a Lyophilized Human Rabies Vaccine (Vero Cells) in Healthy Participants Aged 10–60 Years Following Essen and Zagreb Vaccination Procedures. Vaccines 11:8, pages 1311.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.